Impact of in vitro evolution on antigenic diversity of Mycobacterium bovis bacillus Calmette-Guerin (BCG)
about
Evolutionary landscape of the Mycobacterium tuberculosis complex from the viewpoint of PhoPR: implications for virulence regulation and application to vaccine developmentConsequences of genomic diversity in Mycobacterium tuberculosisCurrent efforts and future prospects in the development of live mycobacteria as vaccinesCo-evolution of Mycobacterium tuberculosis and Homo sapiensEvaluation of the Antibody in Lymphocyte Supernatant Assay to Detect Active Tuberculosis.In vivo biosynthesis of terpene nucleosides provides unique chemical markers of Mycobacterium tuberculosis infectionGenomic expression catalogue of a global collection of BCG vaccine strains show evidence for highly diverged metabolic and cell-wall adaptations.A side-by-side comparison of T cell reactivity to fifty-nine Mycobacterium tuberculosis antigens in diverse populations from five continents.MTBVAC vaccine is safe, immunogenic and confers protective efficacy against Mycobacterium tuberculosis in newborn mice.The Bioinformatics Analysis of Comparative Genomics of Mycobacterium tuberculosis Complex (MTBC) Provides Insight into Dissimilarities between Intraspecific Groups Differing in Host Association, Virulence, and Epitope Diversity.Towards new TB vaccines: What are the challenges?Revaccination of Guinea Pigs With the Live Attenuated Mycobacterium tuberculosis Vaccine MTBVAC Improves BCG's Protection Against Tuberculosis.MTBVAC from discovery to clinical trials in tuberculosis-endemic countries.The BCG Strain Pool: Diversity Matters.Vaccine research and development: tuberculosis as a global health threat.Suboptimal Antigen Presentation Contributes to Virulence of Mycobacterium tuberculosis In Vivo.Reprogramming the T Cell Response to Tuberculosis.Reactogenicity to major tuberculosis antigens absent in BCG is linked to improved protection against Mycobacterium tuberculosis.Mycobacterium tuberculosis Complex Exhibits Lineage-Specific Variations Affecting Protein Ductility and Epitope Recognition.A Promising Listeria-Vectored Vaccine Induces Th1-Type Immune Responses and Confers Protection Against Tuberculosis.Mycobacterium tuberculosis components expressed during chronic infection of the lung contribute to long-term control of pulmonary tuberculosis in mice.The Troika Host-Pathogen-Extrinsic Factors in Tuberculosis: Modulating Inflammation and Clinical Outcomes.MTBVAC: Attenuating the Human Pathogen of Tuberculosis (TB) Toward a Promising Vaccine against the TB Epidemic.A phase I, open-label trial on the safety and immunogenicity of the adjuvanted tuberculosis subunit vaccine H1/IC31® in people living in a TB-endemic area.The Nature and Evolution of Genomic Diversity in the Mycobacterium tuberculosis Complex.A High Throughput Whole Blood Assay for Analysis of Multiple Antigen-Specific T Cell Responses in Human Mycobacterium tuberculosis Infection.
P2860
Q26778612-02AB3721-1C13-4F26-89EA-8B3163733E24Q26851285-7EB6C743-FCA1-4478-BF88-4935F9B37CECQ28087077-88C5DA39-7452-4AFD-A89E-F7E868DC1D40Q28649483-B0DE1119-A4CE-48EA-A600-FDDD02B59ACFQ30275004-8164DCEA-A838-4B6D-A601-73DAEA4F110BQ35608544-EC24A599-84FE-44AA-A637-18C3A0E19C28Q36187495-65F104BC-6276-4C7B-872C-DF754CFD37C0Q36338571-769B237A-B97C-4C3E-8FCC-7815497A98FEQ36504099-7A345A7B-6C50-4C5B-AD2E-89B492B2128CQ37713748-D5D56478-A73F-4927-ABC5-CF60301AE7E1Q38767468-E1ACCE54-A998-4763-9B47-17E0943DDF72Q38886409-A49EB37F-57D5-4BC6-B3F9-DB041D9A3402Q39266421-032B83CC-5724-4B0E-97DF-E39364F41290Q39788557-BC43BCCD-96CC-4C9D-BDC0-4024C84E7812Q40059597-A3FCF043-7A26-49F1-88E2-F6DBD8F39C5EQ40316247-16FFC8E1-6E37-46C4-8C6B-5049084CDDF5Q40829662-D6D484E1-E96E-45C3-B083-B108BA0F858BQ41077364-E4438CEA-EB64-4FE7-B721-4BF06ACD576EQ41089843-AAC74506-7B76-46A4-9B3E-1A5F17A0DC07Q42369903-BED774C2-BC17-4C80-A14F-8AAA6386DB2EQ47159990-EE9B4A5B-DF24-43FA-AE3B-EE8DD5B03C53Q47548481-4467E8E9-9976-4676-8921-B1E53CC04FB7Q47658864-FC9BD7CF-9813-4A19-803A-F8091D7A8FD8Q48268531-1399B613-686A-499C-94F7-E3FF7E674DB5Q50108000-35CD47C1-45D0-4CA2-BE91-5816A9F6FA41Q52655450-95E5B4FB-C550-4CE5-8B51-C90D3621A947
P2860
Impact of in vitro evolution on antigenic diversity of Mycobacterium bovis bacillus Calmette-Guerin (BCG)
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Impact of in vitro evolution o ...... bacillus Calmette-Guerin (BCG)
@ast
Impact of in vitro evolution o ...... bacillus Calmette-Guerin (BCG)
@en
type
label
Impact of in vitro evolution o ...... bacillus Calmette-Guerin (BCG)
@ast
Impact of in vitro evolution o ...... bacillus Calmette-Guerin (BCG)
@en
prefLabel
Impact of in vitro evolution o ...... bacillus Calmette-Guerin (BCG)
@ast
Impact of in vitro evolution o ...... bacillus Calmette-Guerin (BCG)
@en
P2860
P50
P1433
P1476
Impact of in vitro evolution o ...... bacillus Calmette-Guerin (BCG)
@en
P2093
Mireia Coscollá
Sebastien Gagneux
P2860
P304
P356
10.1016/J.VACCINE.2014.07.113
P407
P577
2014-09-06T00:00:00Z